Results 221 to 230 of about 267,329 (233)
Some of the next articles are maybe not open access.

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis

Kidney International, 2004
Michael Jones, Lloyd Ibels
exaly  

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C

Journal of Hepatology, 2004
Jesse Green   +2 more
exaly  

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

Clinical Therapeutics, 2003
Lee S Schwartzberg   +2 more
exaly  

Nanofibrillated cellulose from Alfa, Eucalyptus and Pine fibres: Preparation, characteristics and reinforcing potential

Carbohydrate Polymers, 2011
Sami Boufi, Manuel Rei Vilar
exaly  

Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure

Advances in Therapy, 2007
Mehmet Kanbay   +2 more
exaly  

Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

American Journal of Health-System Pharmacy, 2005
Jon D Herrington, Ralph V Boccia
exaly  

Darbepoetin alfa for the treatment of anemic patients with low- and intermediate-1-risk myelodysplastic syndromes

Annals of Oncology, 2005
G Lanzetta, E Terzoli
exaly  

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)

Journal of Hepatology, 2002
Rajender Reddy   +2 more
exaly  

A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon

Journal of Hepatology, 1996
Giovanna Fattovich   +2 more
exaly  

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Blood, 2019
David Leibowitz   +2 more
exaly  
editorial
fad stu
enterobacterales
research
omega
previous   21  22  23  24  

Home - About - Disclaimer - Privacy